BR9913490A - Cyclic prosaposine and its uses - Google Patents

Cyclic prosaposine and its uses

Info

Publication number
BR9913490A
BR9913490A BR9913490-0A BR9913490A BR9913490A BR 9913490 A BR9913490 A BR 9913490A BR 9913490 A BR9913490 A BR 9913490A BR 9913490 A BR9913490 A BR 9913490A
Authority
BR
Brazil
Prior art keywords
cyclic
prosaposine
derived
peptides
saposin
Prior art date
Application number
BR9913490-0A
Other languages
Portuguese (pt)
Inventor
David E Wright
John
S O'obrien
Original Assignee
Myelos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Myelos Corp filed Critical Myelos Corp
Publication of BR9913490A publication Critical patent/BR9913490A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)

Abstract

"PEPTìDIOS DERIVADOS DE PROSAPOSINA CìCLICOS E SEUS USOS" A invenção se refere a peptídios cíclicos derivados de saposina C que apresentam efeitos neurotróficos e analgésicos."CYCLIC PROSAPOSIN DERIVED PEPTIDES AND THEIR USES" The invention relates to cyclic peptides derived from saposin C that have neurotrophic and analgesic effects.

BR9913490-0A 1998-08-28 1999-08-20 Cyclic prosaposine and its uses BR9913490A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9835998P 1998-08-28 1998-08-28
PCT/US1999/019378 WO2000012553A1 (en) 1998-08-28 1999-08-20 Cyclic prosaposin-derived peptides and uses thereof

Publications (1)

Publication Number Publication Date
BR9913490A true BR9913490A (en) 2001-09-25

Family

ID=22268937

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9913490-0A BR9913490A (en) 1998-08-28 1999-08-20 Cyclic prosaposine and its uses

Country Status (13)

Country Link
EP (1) EP1105420A1 (en)
JP (2) JP4528443B2 (en)
KR (1) KR20010079695A (en)
CN (1) CN1324367A (en)
AU (1) AU751034B2 (en)
BR (1) BR9913490A (en)
CA (1) CA2341810A1 (en)
CZ (1) CZ2001655A3 (en)
HU (1) HUP0103265A3 (en)
IL (1) IL141586A0 (en)
PL (1) PL204359B1 (en)
WO (1) WO2000012553A1 (en)
ZA (1) ZA200102489B (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571787A (en) 1993-07-30 1996-11-05 Myelos Corporation Prosaposin as a neurotrophic factor
IL141586A0 (en) * 1998-08-28 2002-03-10 Myelos Corp Cyclic prosaposin-derived peptide and uses thereof
AUPQ084899A0 (en) * 1999-06-08 1999-07-01 University Of Melbourne, The Neurotrophin agonists
IL137820A (en) * 2000-08-10 2009-06-15 S I S Shulov Inst For Science Pharmaceutical composition for topical administration comprising an analgesic peptide
CN100366286C (en) * 2003-04-28 2008-02-06 常州南云科技有限公司 Saposin C-DOPS: a novel anti-tumor agent
EP3357490A1 (en) 2006-04-28 2018-08-08 Children's Hospital Medical Center Fusogenic properties of saposin c and related proteins and polypeptides for application to transmembrane drug delivery systems
BRPI0717475A2 (en) * 2006-10-20 2014-03-11 Childrens Hosp Medical Center UNILAMELAR SPONTANEOUS PHILOSPHOLIPID UNILAMELAR VESICULES
CN103275187B (en) * 2013-06-14 2014-10-29 四川合泰新光生物科技有限公司 Analgesic peptide FI as well as genes and application thereof
CA2982480C (en) 2015-04-23 2021-04-13 The Procter & Gamble Company Delivery of surfactant soluble anti-dandruff agent
MX2018010551A (en) 2016-03-03 2018-11-09 Procter & Gamble Aerosol antidandruff composition.
EP3528894A1 (en) 2016-10-21 2019-08-28 The Procter and Gamble Company Concentrated shampoo dosage of foam for providing hair care benefits
US10842720B2 (en) 2016-10-21 2020-11-24 The Procter And Gamble Company Dosage of foam comprising an anionic/zwitterionic surfactant mixture
WO2018075832A1 (en) 2016-10-21 2018-04-26 The Procter & Gamble Company Stable compact shampoo products with low viscosity and viscosity reducing agent
EP3528897A1 (en) 2016-10-21 2019-08-28 The Procter & Gamble Company Dosage of foam for delivering consumer desired dosage volume, surfactant amount, and scalp health agent amount in an optimal formulation space
CN109862941A (en) 2016-10-21 2019-06-07 宝洁公司 For providing the concentrated type shampoo foam of hair-care beneficial effect
WO2018075847A1 (en) 2016-10-21 2018-04-26 The Procter & Gamble Company Concentrated shampoo dosage of foam designating hair volume benefits
EP3528898A1 (en) 2016-10-21 2019-08-28 The Procter and Gamble Company Concentrated shampoo dosage of foam designating hair conditioning benefits
US11679073B2 (en) 2017-06-06 2023-06-20 The Procter & Gamble Company Hair compositions providing improved in-use wet feel
US11141370B2 (en) 2017-06-06 2021-10-12 The Procter And Gamble Company Hair compositions comprising a cationic polymer mixture and providing improved in-use wet feel
US11224567B2 (en) 2017-06-06 2022-01-18 The Procter And Gamble Company Hair compositions comprising a cationic polymer/silicone mixture providing improved in-use wet feel
WO2019074991A1 (en) 2017-10-10 2019-04-18 The Procter & Gamble Company Compact shampoo composition with amino acid based anionic surfactants and cationic polymers
US11116703B2 (en) 2017-10-10 2021-09-14 The Procter And Gamble Company Compact shampoo composition containing sulfate-free surfactants
JP6974928B2 (en) 2017-10-10 2021-12-01 ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company Compact shampoo composition
WO2019074988A1 (en) 2017-10-10 2019-04-18 The Procter & Gamble Company A method of treating hair or skin with a personal care composition in a foam form
CN111556743B (en) 2017-12-20 2023-07-18 宝洁公司 Clear shampoo compositions comprising silicone polymers
JP2021528410A (en) 2018-06-29 2021-10-21 ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ Low Surfactant Aerosol Antidandruff Composition
CA3159404A1 (en) 2019-12-06 2021-06-10 The Procter & Gamble Company Sulfate free composition with enhanced deposition of scalp active
US11679065B2 (en) 2020-02-27 2023-06-20 The Procter & Gamble Company Compositions with sulfur having enhanced efficacy and aesthetics
CN116568263A (en) 2020-12-04 2023-08-08 宝洁公司 Hair care composition comprising malodor reduction materials
US11771635B2 (en) 2021-05-14 2023-10-03 The Procter & Gamble Company Shampoo composition
US11986543B2 (en) 2021-06-01 2024-05-21 The Procter & Gamble Company Rinse-off compositions with a surfactant system that is substantially free of sulfate-based surfactants

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6271196B1 (en) * 1996-03-05 2001-08-07 Regents Of The University Of Ca Methods of alleviating neuropathic pain using prosaposin-derived peptides
IL141586A0 (en) * 1998-08-28 2002-03-10 Myelos Corp Cyclic prosaposin-derived peptide and uses thereof

Also Published As

Publication number Publication date
IL141586A0 (en) 2002-03-10
CZ2001655A3 (en) 2001-11-14
EP1105420A1 (en) 2001-06-13
HUP0103265A2 (en) 2002-02-28
ZA200102489B (en) 2002-06-04
CN1324367A (en) 2001-11-28
PL204359B1 (en) 2010-01-29
CA2341810A1 (en) 2000-03-09
JP2010150272A (en) 2010-07-08
AU5690599A (en) 2000-03-21
KR20010079695A (en) 2001-08-22
AU751034B2 (en) 2002-08-08
JP4528443B2 (en) 2010-08-18
PL346346A1 (en) 2002-02-11
HUP0103265A3 (en) 2002-09-30
JP2002523518A (en) 2002-07-30
WO2000012553A1 (en) 2000-03-09

Similar Documents

Publication Publication Date Title
BR9913490A (en) Cyclic prosaposine and its uses
ES2195970T3 (en) L-RIBAVIRINA AND USES OF THE SAME.
NO20012774D0 (en) Preparation and method using essential plant oils
EP0624348A3 (en) Bipolar electrosurgical instruments.
MA25279A1 (en) REFRESHING COMPOSITIONS.
ATE289640T1 (en) AMIDOFUNCTIONAL AMINOPOLYDIORGANOSILOXANES
ITRM960810A0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORINS OR MACROLIDS
DE69210683D1 (en) Endoscopic, bipolar electrosurgical instruments
BR0109943A (en) Pharmaceutical Compositions
ES2081870T3 (en) PLASTO-ELASTIC POLYPROPYLENE COMPOSITIONS.
PT817847E (en) IL-17 RECEPTOR
MX9206423A (en) PERFUME COMPOSITION.
BR9911724A (en) Cyclosporine that has an improved activity profile
DE69723277D1 (en) Vapor Sterilization Indicating Compositions
IT1302347B1 (en) PROCEDURE FOR THE DIRECT PRODUCTION OF HYDROGEN PEROXIDE.
DE69202620D1 (en) Silicone defoamer composition.
DE69300694D1 (en) Disinfectant compositions.
DE59401899D1 (en) Adjustable column for chairs, tables or the like.
BG102589A (en) 3-azetidinylalkylpiperidines or -pyrrolidines as tachykin antagonists
ES2170143T3 (en) COMPOSITIONS THAT INCLUDE HALOFANTRINE IN A SPECIAL FORM.
MX9204623A (en) COMPOSITE OF BIS-4-PIPERIDIL-PHOSPHITE N-METHYLATED.
IT1303736B1 (en) PEPTIDES DERIVED FROM RANTES WITH ANTI-HIV ACTIVITY.
TR199601012A2 (en) Shampoo composition.
IL139531A0 (en) Human antithrombin iii, methods for the production thereof and pharmaceutical compositions containing the same
PT633928E (en) MICRORGANISMS PREPARATION AND USES PROCESS

Legal Events

Date Code Title Description
PC Transfer

Free format text: MYLS ACQUISITIONS CORP (US)

TC Change of name
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007.